300 related articles for article (PubMed ID: 20081091)
1. PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans.
Soond DR; Bjørgo E; Moltu K; Dale VQ; Patton DT; Torgersen KM; Galleway F; Twomey B; Clark J; Gaston JS; Taskén K; Bunyard P; Okkenhaug K
Blood; 2010 Mar; 115(11):2203-13. PubMed ID: 20081091
[TBL] [Abstract][Full Text] [Related]
2. ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis.
Aragoneses-Fenoll L; Montes-Casado M; Ojeda G; Acosta YY; Herranz J; Martínez S; Blanco-Aparicio C; Criado G; Pastor J; Dianzani U; Portolés P; Rojo JM
Biochem Pharmacol; 2016 Apr; 106():56-69. PubMed ID: 26883061
[TBL] [Abstract][Full Text] [Related]
3. The p110δ subunit of PI3K regulates bone marrow-derived eosinophil trafficking and airway eosinophilia in allergen-challenged mice.
Kang BN; Ha SG; Ge XN; Reza Hosseinkhani M; Bahaie NS; Greenberg Y; Blumenthal MN; Puri KD; Rao SP; Sriramarao P
Am J Physiol Lung Cell Mol Physiol; 2012 Jun; 302(11):L1179-91. PubMed ID: 22427531
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Phosphoinositide 3-Kinase p110delta Does Not Affect T Cell Driven Development of Type 1 Diabetes Despite Significant Effects on Cytokine Production.
Barbera Betancourt A; Emery JL; Recino A; Wong FS; Cooke A; Okkenhaug K; Wallberg M
PLoS One; 2016; 11(1):e0146516. PubMed ID: 26783747
[TBL] [Abstract][Full Text] [Related]
5. Selective pharmacological inhibition of phosphoinositide 3-kinase p110delta opposes the progression of autoimmune diabetes in non-obese diabetic (NOD) mice.
Durand CA; Richer MJ; Brenker K; Graves M; Shanina I; Choi K; Horwitz MS; Puri KD; Gold MR
Autoimmunity; 2013 Feb; 46(1):62-73. PubMed ID: 23039284
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model.
Lee KS; Lee HK; Hayflick JS; Lee YC; Puri KD
FASEB J; 2006 Mar; 20(3):455-65. PubMed ID: 16507763
[TBL] [Abstract][Full Text] [Related]
7. Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategy.
Law AJ; Wang Y; Sei Y; O'Donnell P; Piantadosi P; Papaleo F; Straub RE; Huang W; Thomas CJ; Vakkalanka R; Besterman AD; Lipska BK; Hyde TM; Harrison PJ; Kleinman JE; Weinberger DR
Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12165-70. PubMed ID: 22689948
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 13 increases contractility of murine tracheal smooth muscle by a phosphoinositide 3-kinase p110delta-dependent mechanism.
Farghaly HS; Blagbrough IS; Medina-Tato DA; Watson ML
Mol Pharmacol; 2008 May; 73(5):1530-7. PubMed ID: 18276774
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of PI3Kδ Enhances Poly I:C-Induced Antiviral Responses and Inhibits Replication of Human Metapneumovirus in Murine Lungs and Human Bronchial Epithelial Cells.
Fujita A; Kan-O K; Tonai K; Yamamoto N; Ogawa T; Fukuyama S; Nakanishi Y; Matsumoto K
Front Immunol; 2020; 11():432. PubMed ID: 32218789
[TBL] [Abstract][Full Text] [Related]
10. The phosphoinositide 3'-kinase p110δ modulates contractile protein production and IL-6 release in human airway smooth muscle.
Ge Q; Moir LM; Trian T; Niimi K; Poniris M; Shepherd PR; Black JL; Oliver BG; Burgess JK
J Cell Physiol; 2012 Aug; 227(8):3044-52. PubMed ID: 22015454
[TBL] [Abstract][Full Text] [Related]
11. Phosphoinositide 3-kinase p110 delta regulates natural antibody production, marginal zone and B-1 B cell function, and autoantibody responses.
Durand CA; Hartvigsen K; Fogelstrand L; Kim S; Iritani S; Vanhaesebroeck B; Witztum JL; Puri KD; Gold MR
J Immunol; 2009 Nov; 183(9):5673-84. PubMed ID: 19843950
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 3-Kinase p110δ Isoform Regulates CD8+ T Cell Responses during Acute Viral and Intracellular Bacterial Infections.
Gracias DT; Boesteanu AC; Fraietta JA; Hope JL; Carey AJ; Mueller YM; Kawalekar OU; Fike AJ; June CH; Katsikis PD
J Immunol; 2016 Feb; 196(3):1186-98. PubMed ID: 26740110
[TBL] [Abstract][Full Text] [Related]
13. The p110 delta isoform of phosphatidylinositol 3-kinase controls the quality of secondary anti-Leishmania immunity by regulating expansion and effector function of memory T cell subsets.
Liu D; Uzonna JE
J Immunol; 2010 Mar; 184(6):3098-105. PubMed ID: 20154209
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-7 promotes the survival of human CD4+ effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway.
Chetoui N; Boisvert M; Gendron S; Aoudjit F
Immunology; 2010 Jul; 130(3):418-26. PubMed ID: 20465565
[TBL] [Abstract][Full Text] [Related]
15. Genetic or pharmaceutical blockade of p110delta phosphoinositide 3-kinase enhances IgE production.
Zhang TT; Okkenhaug K; Nashed BF; Puri KD; Knight ZA; Shokat KM; Vanhaesebroeck B; Marshall AJ
J Allergy Clin Immunol; 2008 Oct; 122(4):811-819.e2. PubMed ID: 19014771
[TBL] [Abstract][Full Text] [Related]
16. PI3Kδ Forms Distinct Multiprotein Complexes at the TCR Signalosome in Naïve and Differentiated CD4
Luff DH; Wojdyla K; Oxley D; Chessa T; Hudson K; Hawkins PT; Stephens LR; Barry ST; Okkenhaug K
Front Immunol; 2021; 12():631271. PubMed ID: 33763075
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of phosphoinositide 3-kinase p110α preserves lymphocyte function.
So L; Yea SS; Oak JS; Lu M; Manmadhan A; Ke QH; Janes MR; Kessler LV; Kucharski JM; Li LS; Martin MB; Ren P; Jessen KA; Liu Y; Rommel C; Fruman DA
J Biol Chem; 2013 Feb; 288(8):5718-31. PubMed ID: 23275335
[TBL] [Abstract][Full Text] [Related]
18. A selective inhibitor of the p110delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16.
Billottet C; Grandage VL; Gale RE; Quattropani A; Rommel C; Vanhaesebroeck B; Khwaja A
Oncogene; 2006 Oct; 25(50):6648-59. PubMed ID: 16702948
[TBL] [Abstract][Full Text] [Related]
19. Phosphoinositide 3-Kinase p110 Delta Differentially Restrains and Directs Naïve Versus Effector CD8
Spinelli L; Marchingo JM; Nomura A; Damasio MP; Cantrell DA
Front Immunol; 2021; 12():691997. PubMed ID: 34220851
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of PI3K p110δ activity reduces IgE production in IL-4 and anti-CD40 stimulated human B cell cultures.
Cutrina-Pons A; De Sa A; Fear DJ; Gould HJ; Ramadani F
Immunology; 2023 Dec; 170(4):483-494. PubMed ID: 37530226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
